Whitehawk Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.79	37.57	28.67	62.89	39.02	148.99
Short-Term Investments	88.25	108.13	18.57	45.96	133.54	-
Cash & Short-Term Investments	123.04	145.7	47.24	108.85	172.56	148.99
Cash Growth	-46.75%	208.44%	-56.60%	-36.92%	15.82%	3244.31%
Accounts Receivable	-	-	5.9	5.49	1.86	-
Inventory	-	-	5.31	6.43	1.86	-
Other Current Assets	2.51	3.32	2.84	3.83	3.75	2.28
Total Current Assets	125.55	149.01	61.29	124.59	180.03	151.27
Net Property, Plant & Equipment	0	0	7.63	5.97	2.03	0.61
Other Intangible Assets	-	-	-	-	-	3.81
Other Long-Term Assets	1.68	1.81	1.4	1.87	2.18	2.21
Total Assets	127.23	150.83	70.32	132.42	184.24	157.91
Accounts Payable	1.75	0.92	2.16	5.9	3.52	6.44
Accrued Expenses	9.31	13.6	14.65	14.31	14.92	8.7
Current Portion of Leases	-	-	0.27	0.43	0.39	0.13
Other Current Liabilities	-	-	-	5.76	-	-
Total Current Liabilities	11.06	14.52	17.07	26.4	18.84	15.27
Long-Term Leases	-	-	0.57	0.83	1.27	0.47
Other Long-Term Liabilities	-	-	0.2	-	5.76	5.76
Total Long-Term Liabilities	-	-	0.77	0.83	7.02	6.23
Total Liabilities	11.06	14.52	17.84	27.23	25.86	21.5
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	491.63	489.44	385.11	374.13	361.69	279.09
Accumulated Other Comprehensive Income	-0.02	0.12	0.02	0.03	-0.12	-
Retained Earnings	-375.44	-353.25	-332.65	-268.96	-203.2	-142.69
Shareholders' Equity	116.18	136.31	52.48	105.2	158.38	136.41
Total Liabilities & Equity	127.23	150.83	70.32	132.42	184.24	157.91
Total Debt	-	0	0.83	1.27	1.66	0.61
Net Cash (Debt)	123.04	145.7	46.4	107.58	170.9	148.38
Net Cash Growth	-15.55%	213.97%	-56.87%	-37.05%	15.17%	3326.88%
Net Cash Per Share	1.78	2.35	1.72	4.00	7.59	16.63
Book Value	116.18	136.31	52.48	105.2	158.38	136.41
Book Value Per Share	1.68	2.20	1.94	3.91	7.04	15.29
Tangible Book Value	116.18	136.31	52.48	105.2	158.38	132.6
Tangible Book Value Per Share	1.68	2.20	1.94	3.91	7.04	14.86

SEC Filings: 10-K · 10-Q